Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Paul R. Menard is active.

Publication


Featured researches published by Paul R. Menard.


Tetrahedron Letters | 1998

Applications of N-BOC-diamines for the solution phase synthesis of ketopiperazine libraries utilizing a Ugi/De-BOC/Cyclization (UDC) strategy

Christopher Hulme; John Peng; Bonnie Louridas; Paul R. Menard; Paul Krolikowski; N.Vasant Kumar

Abstract This communication reveals a novel application of the ‘so-called’ convertible isonitrile for the solution phase generation of ketopiperazine libraries. Use of mono N-BOC diamines in the Ugi multi-component reaction (MCR), followed by BOC removal and base treatment (a ‘3 step, 1-pot procedure’) affords ketopiperazines in good yield. The generality of this procedure was further explored revealing novel routes to dihydroquinoxalinones and 1,4-benzodiazepines respectively


Journal of Chemical Information and Computer Sciences | 1998

Chemistry Space Metrics in Diversity Analysis, Library Design, and Compound Selection

Paul R. Menard; Jonathan S. Mason; Isabelle Morize; Susanne Bauerschmidt

DiverseSolutions software was used to generate a “universal” chemistry space that can be used as a standard for profiling most structural sets of interest. A nonlinear method for assigning structures to bins within chemistry space descriptors was developed. This allows the use of chemistry spaces scaled to include all structures within a set, while maintaining a reasonable distribution of structures within bins and providing target percentage cell occupancies. The universal chemistry space and nonlinear binning method were validated using random structures extracted from the Beilstein database. The approach was then used, in conjunction with other diversity analyses, for diverse subset selection and comparison of compound collections.


Journal of Chemical Information and Computer Sciences | 1998

RATIONAL SCREENING SET DESIGN AND COMPOUND SELECTION : CASCADED CLUSTERING

Paul R. Menard; Richard A. Lewis; Jonathan S. Mason

The use of cascaded clustering is reported. This technique was developed to permit the application of Jarvis-Patrick clustering based on structural fingerprints to large chemical databases, while keeping the maximum cluster size and the number of singletons produced at reasonable levels. The basis for the algorithm, its implementation, and validation are described. In the first part of the paper, the approach is used to create a representative subset of compounds for biological testing from the corporate compound repository. A variation of the method is then used for the comparison of relatively large databases. Finally, compound selection using cascaded clustering is shown to be complementary to the Diverse Property-Derived approach, which is based on partitioning by six molecular descriptors.


Molecular Diversity | 1998

Synthesis and diversity analysis of lead discovery piperazine-2-carboxamide libraries

Timothy F. Herpin; George C. Morton; Allison K. Dunn; Cedric Fillon; Paul R. Menard; Sheng Yu Tang; Joseph M. Salvino; Richard Labaudiniere

A Lead Discovery Library ofpiperazine-2-carboxamide derivatives was produced forgeneral screening. This paper discloses two novelsolid phase synthetic routes used to produce 15 000single compounds via the Irori directed sortingtechnique. Computational methods such as reagentclustering and library profiling were used to maximizereagent diversity and optimize pharmacokineticparameters. The results of a four center pharmacophoreanalysis revealed the added diversity gained by usingtwo independent synthetic routes.


Journal of Medicinal Chemistry | 1999

New 4-Point Pharmacophore Method for Molecular Similarity and Diversity Applications: Overview of the Method and Applications, Including a Novel Approach to the Design of Combinatorial Libraries Containing Privileged Substructures

Jonathan S. Mason; Isabelle Morize; Paul R. Menard; Daniel L. Cheney; Christopher Hulme; Richard Labaudiniere


Journal of Medicinal Chemistry | 1986

Angiotensin-converting enzyme inhibitors: new orally active 1,4-thiazepine-2,5-diones, 1,4-thiazine-2,5-diones, and 1,4-benzothiazepine-2,5-diones possessing antihypertensive activity

Jerry W. Skiles; John T. Suh; Williams Be; Paul R. Menard; Jeffrey N. Barton; Bernard Loev; Howard Jones; Edward S. Neiss; Alfred Schwab; Mann Ws


Archive | 1984

Compounds for treating hypertension

John J. Piwinski; John T. Suh; Paul R. Menard; Howard Jones; Edward S. Neiss


Archive | 1988

Treatment of conditions requiring enhanced oxygen availability to mammalian tissues

Robert G. Pendleton; E. Pendley Ii Charles; John T. Suh; Kin T. Yu; Paul R. Menard; Tihamer Herczeg


Journal of Medicinal Chemistry | 1985

Angiotensin converting enzyme inhibitors. (Mercaptoaroyl)amino acids

Paul R. Menard; John T. Suh; Howard Jones; Bernard Loev; Edward S. Neiss; Joyce Wilde; Alfred Schwab; William S. Mann


Journal of Medicinal Chemistry | 1990

Angiotensin converting enzyme inhibitors. 10. Aryl sulfonamide substituted N-[1-carboxy-3-phenylpropyl]-L-alanyl-L-proline derivatives as novel antihypertensives

James J. Mencel; John R. Regan; Jeffrey N. Barton; Paul R. Menard; Joseph G. Bruno; Raul R. Calvo; Brian Edward Kornberg; Alfred Schwab; Edward S. Neiss; John T. Suh

Collaboration


Dive into the Paul R. Menard's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge